Carlos Rodriguez-Galindo on Treating Rare Pediatric Cancer
Carlos Rodriguez-Galindo, MD, chair of the Department of Global Pediatric Medicine and director of the International Outreach Program at St. Jude Children’s Research Hospital, and chair of the rare tumor committee at the Children’s Oncology Group, discusses treating rare pediatric cancers.
Carlos Rodriguez-Galindo, MD, chair of the Department of Global Pediatric Medicine and director of the International Outreach Program at St. Jude Children’s Research Hospital, and chair of the rare tumor committee at the Children’s Oncology Group, discusses treating rare pediatric cancers.
Pediatric cancer makes up only about 1% of all cancers, so rare pediatric cancer types, such as liver tumors, germ cell tumors, and carcinomas are particularly difficult to treat because research is lagging due to their small numbers. So, about ten years ago, the Children’s Oncology Group established a committee that would focus solely on rare tumor types, leading to multiple clinical trials and advancements.
